Furthermore, our data indicated that the inhibition of PD-1+ and Tim-3+ significantly enhanced tumor-infiltrating CD4+/CD8+ T-cells IFN-γ secretion in patients with GC compared with the control group. This evidence concerns the gene CD8A and gastric cancer.